Previous 10 | Next 10 |
2023-11-21 13:10:50 ET DENVER, Colo., Nov. 20, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; ProKidney Corp (NASDAQ: PROK), Can Fite Biofarma Ltd (AMEX: CANF), Seres Therapeutics Inc (NASDAQ: MCR...
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics PR Newswire Quotient's Somatic Genomics platform reveals new approaches to treat disease based on the vast genetic variation present in the body's trilli...
2023-11-20 12:59:05 ET Gainers: Mira Pharmaceuticals ( MIRA ) +58% . YPF ADR ( YPF ) +39% . Altamira Therapeutics Ltd ( CYTO ) +39% . ProKidney Corp ( PROK ) +35% . Soluna Holdings ( SLNH ) +32% . Safety Shot ( SHOT ) +...
2023-11-12 02:01:12 ET Summary Considering current Seres valuation and Q3 update risk-reward has improved considerably. However, pending more updates on commercial uptake of VOWST and payer coverage risk remains high. Restructuring, including reduction of workforce by 41% and paus...
2023-11-12 01:53:51 ET Summary Seres's FDA-approved Vowst faces commercial challenges despite clinical success, impacting financials with increased losses and share dilution. Despite a decent cash runway, Seres's stockholders' deficit and substantial long-term liabilities suggest ...
2023-11-04 11:52:09 ET Seres Therapeutics, Inc. (MCRB) Q3 2023 Results Conference Call November 02, 2023 08:00 AM ET Company Participants Kevin Mannix - Head, IR Eric Shaff - CEO Dr. Terri Young - Chief Commercial Officer David Arkowitz - CFO Conference...
2023-11-02 13:15:49 ET More on etc. Dynatrace, Inc. (DT) Q2 2024 Earnings Call Transcript Geron Corporation 2023 Q3 - Results - Earnings Call Presentation Gates Industrial: Encouraging Q3 Report Needed To Finally Create A Floor For The Stock Icahn Enterprises...
2023-11-02 08:10:36 ET More on Seres Therapeutics Seres: VOWST Is A Great Product But Commercialization Prospects Unclear Due To Very High Price Seres Therapeutics: Approved Drug And Nestle Partnership Make It A Buy Seres Therapeutics, Inc. (MCRB) Q2 2023 Earnings Ca...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Rapid growth of VOWST continues with more than 1,500 patient enrollment forms received since FDA approval Announces strategic restructuring to focus resources and investment on continued VOWST growth, completion of SER-155 Phase 1b study, and supporting longer-term business sustainabi...
News, Short Squeeze, Breakout and More Instantly...
Seres Therapeutics Inc. Company Name:
MCRB Stock Symbol:
NASDAQ Market:
Seres Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 20.3% to $0.0699 on volume of 164,902,840 shares Safe and Green Development Corporation (SGD) rose 36.7% to $0.8477 on volume of 100,466,382 shares PROSHARES TRUST (SQQQ) fell 0.6% to $1...
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial resu...
A look at the top 10 most actives in the United States iSun Inc. (ISUN) rose 51.4% to $0.1998 on volume of 132,838,583 shares Reborn Coffee Inc. (REBN) rose 84.4% to $3.19 on volume of 109,626,591 shares PROSHARES TRUST (SQQQ) rose 0.2% to $10.74 on volume of 99,444,834 shares Nikola Co...